ARMK

• Operating income rose 18% to $216 million; adjusted operating income grew 13% to $261 million on a constant currency basis.
• GAAP EPS increased 34% to $0.36; adjusted EPS rose 29% to $0.52 on a constant currency basis.
• Company raised full-year organic revenue growth outlook to +9% to +10%, reaffirmed AOI growth of +12% to +17%, adjusted EPS growth of +20% to +25%, and leverage ratio under 3x.
• New client wins exceeded $1.6 billion fiscal year to date, up 51% year-over-year; client retention at record ~98%.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• On August 4, 2026, Aramark's Board increased its size to 12 directors and elected Antony F. Spring, age 61, as a director.
• Mr. Spring is Chairman and CEO of Macy's, Inc., a role he has held since 2024, and previously served as President of Macy's and CEO of Bloomingdale's.
• There are no arrangements or understandings with other persons regarding his appointment, and no family relationships with Aramark directors or executive officers.
• Mr. Spring is eligible for Aramark's non-employee director compensation program and will enter into the company's standard indemnification agreement.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

• Consolidated revenue was $4.9 billion in Q2 FY2026, up 15% year-over-year; Organic Revenue rose 12%.
• GAAP EPS rose 65% to $0.38; Adjusted EPS increased 40% to $0.49.
• Net cash from operations was $400 million, up 56%; Free Cash Flow was $305 million, up 116%.
• Company updated fiscal 2026 outlook to high end of +7% to +9% Organic Revenue growth; reaffirmed AOI growth +12% to +17%, Adjusted EPS growth +20% to +25%, leverage under 3x.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• Each grant has a fair value of $3,000,000, effective February 19, 2026.
• RSUs vest on the earlier of the third anniversary of grant or six months after a permanent successor CEO commences employment, subject to continued employment.
• Accelerated vesting is provided for certain qualifying termination events, but not voluntary retirement.
• The grants were disclosed under Item 5.02 and Item 7.01 of Form 8-K.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 7.01 Regulation FD Disclosure

• Consolidated revenue was $4.8 billion in Q1 fiscal 2026, a 6% increase year-over-year; organic revenue grew 5%.
• GAAP EPS was $0.36, down 8%; adjusted EPS was unchanged at $0.51.
• The company repurchased $30 million of stock and repriced $2.4 billion of 2030 Term Loan B, reducing interest rates by 25 basis points.
• Fiscal 2026 outlook: revenue $19.55–$19.95 billion, AOI $1.10–$1.15 billion, adjusted EPS $2.18–$2.28, leverage under 3x.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• Aramark held its 2026 Annual Meeting of Shareholders on February 3, 2026.
• Shareholders ratified the appointment of Deloitte & Touche LLP as independent auditor for fiscal year ending October 2, 2026.
• The non-binding advisory vote on executive compensation was approved.
• The meeting results were reported under Item 5.07 as required by SEC rules.

5.07 Submission of Matters to a Vote of Security Holders

• The amendment refinances the entire $2,384,140,862.90 principal amount of U.S. Term B-8 Loans with new U.S. Term B-10 Loans due in June 2030.
• The new Term B-10 Loans bear interest at Term SOFR plus 1.75% or base rate plus 0.75%, at the company's election.
• Quarterly principal repayments of $6,290,609.14 are required from December 31, 2028 through March 31, 2030.
• The new loans are subject to substantially similar guarantees, collateral, mandatory prepayments, and covenants as the prior Term B-8 Loans.

1.01 Entry into a Material Definitive Agreement

• Fiscal 2025 consolidated revenue was $18.5 billion, up 6% year-over-year, with organic revenue up 7%.
• GAAP EPS for fiscal 2025 was $1.22, up 23%, and adjusted EPS was $1.82, up 19% on a constant-currency basis.
• The company achieved a leverage ratio of 3.25x, the lowest in nearly 20 years, and repurchased over 4 million shares.
• Fiscal 2026 outlook includes organic revenue growth of 7% to 9%, adjusted operating income growth of 12% to 17%, and adjusted EPS growth of 20% to 25%.
• The Board approved a 14% increase in the quarterly dividend to $0.12 per share, payable December 17, 2025.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits